KKR房地产金融信托 KREF 深 沪
已收盘 02-06 16:00:00 美东时间
7.32
+0.050
+0.69%
华盛通- 最 高7.485
- 今 开7.35
- 成交量 130.95万股
- 最 低 7.25
- 昨 收 7.27
- 总市值 4.70亿
- 52周最高 10.53
- 市盈率 静 --
- 换手率 2.04%
- 52周最低 7.2168
- 委 比 18.99%
- 总股本 6427.56万
- 历史最高 17.00
- 量 比 0.91
- 振 幅 3.23%
- 历史最低 -2.04
- 每 手 1
- 风险率 0.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
美股大行评级 | 高露洁棕榄、再生元制药、伊士曼化工、威瑞森、Ameris、丘奇＆德怀特等获多家大行上调目标价
今日重点评级关注：Benchmark：维持Charter Communications"买入"评级，目标价从425美元升至455美元；BTIG：维持LifeStance Health Gr"买入"评级，目标价从10美元升至11美元
02-03 09:06
BTIG Reiterates Buy on KKR Real Est Finance Tr, Maintains $13 Price Target
BTIG analyst Thomas Catherwood reiterates KKR Real Est Finance Tr (NYSE:KREF) with a Buy and maintains $13 price target.
02-02 20:00
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Keefe, Bruyette & Woods Maintains Market Perform on KKR Real Est Finance Tr, Lowers Price Target to $8.25
Keefe, Bruyette & Woods analyst Jade Rahmani maintains KKR Real Est Finance Tr (NYSE:KREF) with a Market Perform and lowers the price target from $8.75 to $8.25.
01-08 23:46
美股大行评级 | 上调目标价！特斯拉、赛默飞世尔、拉姆研究、波士顿科学、安诺电子、金沙集团等获众多机构评级
今日重点评级关注：摩根士丹利：维持Viking Therapeutics"超配"评级，目标价从98美元升至102美元；摩根大通：维持IDEAYA Biosciences"超配"评级，目标价从74美元升至79美元
2025-10-24 09:51
KREF outlines $1.5B+ repayments target for 2026 as European expansion accelerates
Earnings Call Insights: KKR Real Estate Finance Trust Inc. (KREF) (KREF) Q3 2025 Management View CEO Matthew Salem emphasized the robust pipeline in the commercial real estate lending market, pointing...
2025-10-23 00:34
KKR Real Estate Finance Q3 Adj. EPS $(0.03) Misses $0.10 Estimate
KKR Real Estate Finance (NYSE:KREF) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.10 by 129.13 percent. This is a 108.11 percent decrease over earnings of $0.37 per
2025-10-22 04:19
KKR Real Estate Finance Trust distributable loss of -$0.03
KKR Real Estate Finance Trust press release (NYSE:KREF): Q3 distributable loss of -$0.03. More on KKR Real Estate Finance Trust KKR Real Estate Finance: A Dip In Book Value KKR Real Estate Finance: 10...
2025-10-22 04:17
Earnings Scheduled For October 21, 2025
Companies Reporting Before The Bell • Valmont Industries (NYSE:VMI) is estimate...
2025-10-21 16:32
